Current Illinois CancerCare Clinical Trials

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery-Suspended

Study Number: EA2161-Suspended

Status: Suspended

Study Coordinator(s)
  • Navigator Carrie, 309-243-3621 cgeoffroy@illinoiscancercare.com
  • Alyssa, 309-243-3626, awagner@illinoiscancercare.com

Study Link

« Search Again